Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Asensus Surgical Inc
ASXC
Healthcare
Medical Devices
Asensus Surgical, Inc. is a medical device company digitizing the interface between the surgeon and patient to reimagine surgery through Performance-Guided Surgery to enable surgeons to deliver outcomes to patients and establish a new standard of surgery. It operates in one business segment, which is the research, development and sale of medical device robotics to improve minimally invasive...
surgery. It is developing the LUNA Surgical System, a robotic and instrument system as a foundation of its Digital Surgery solution. These systems shall be powered by the Intelligent Surgical Unit to enhance surgeon control and reduce surgical variability. With the addition of machine vision, Augmented Intelligence, and deep learning capabilities throughout the surgical experience, it intends to holistically address the clinical, cognitive and economic shortcomings that drive surgical outcomes and value-based healthcare. It is also working to incorporate all of this in the LUNA Surgical System.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NYSEAM:ASXC)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
Next
(25)
•••
tamari
X
View Profile
View Bullboard History
Post by
tamari
on Jan 13, 2023 11:28am
Closing in on 10,000+ proecedures.
That's critical mass of machine learning and opens up a lot of opportunities. The commercial launch of articulating instruments in Q4 2022 was a long sought after key surgeon preference item
...more
(4)
•••
zamani11
X
View Profile
View Bullboard History
Post by
zamani11
on Apr 08, 2022 3:46pm
Robotic Endoscopy Devices Market Post-COVID Income Monitorin
Robotic Endoscopy Devices Market Post-COVID Income Monitoring Trends | Fortune Business Insights™
(25)
•••
tamari
X
View Profile
View Bullboard History
Post by
tamari
on Feb 09, 2022 9:00am
Robotics-Assisted Surgery – Five Predictions for 2022
Asensus Surgical CEO Anthony Fernando extrapolates from current trends, and provides insights into the future of robotics-assisted surgery, digitized surgery and telesurgery. https://www
...more
(25)
•••
tamari
X
View Profile
View Bullboard History
Post by
tamari
on Feb 07, 2022 10:30am
electives - should be on the upswing as Covid recedes
and restrictions are lightened. Asensus progress in the past year looks good considering the environment, while the SP has retraced considerably.
(25)
•••
tamari
X
View Profile
View Bullboard History
Post by
tamari
on Mar 09, 2021 8:39pm
podcast 8-March w/CEO.
https://www.devicetalks.com/arrigato-mr-surgical-roboto-ferre-usen-and-fernando-steer-medtech-toward-digital-surgery/ (~10-32 min.)
(25)
•••
tamari
X
View Profile
View Bullboard History
Post by
tamari
on Mar 03, 2021 10:23pm
BOWA Medical UK released a video today
for the Senhance® Surgical System. https://www.youtube.com/watch?v=23EagOonbXI About BOWA Medical BOWA develops and produces high-specification medical-technology solutions, and since 1977 has
...more
(25)
•••
tamari
X
View Profile
View Bullboard History
Post by
tamari
on Mar 03, 2021 8:16am
Asensus Surgical Announces FDA Clearance in General Surgery
Indications Expand to Include New Procedures in Large General Surgery Market https://www.businesswire.com/news/home/20210303005310/en March 03, 2021 06:55 AM Eastern Standard Time
...more
(25)
•••
tamari
X
View Profile
View Bullboard History
Post by
tamari
on Feb 25, 2021 10:40pm
U.S. sees sharp drop in Covid hosp. admissions.
As BB reported today, we are seeing a steep drop in admissions among the highest age groups in the U.S.. This is welcome news. https://www.bloomberg.com/news/articles/2021-02-25/covid-hospital
...more
(25)
•••
tamari
X
View Profile
View Bullboard History
Post by
tamari
on Feb 09, 2021 10:51am
$5+ opens the gates to further upside.
"When a stock rises over that $5 threshold, institutions and hedge funds can, and sometimes do, load up on shares which in turn drives the price higher." https://www.benzinga.com/general
...more
(25)
•••
tamari
X
View Profile
View Bullboard History
Post by
tamari
on Feb 08, 2021 12:27pm
Senhance evaluation. - Published online: 05 Feb 2021
Robotic cholecystectomy using Senhance robotic platform versus laparoscopic conventional cholecystectomy: a propensity score analysis Narimantas E. Samalavicius , Tadas Kaminskas
...more
(25)
•••
tamari
X
View Profile
View Bullboard History
Post by
tamari
on Feb 05, 2021 2:48pm
correction to prior post (yellow highlight), no change to %
Improving U.S. vaccination & hospitalization data pave the way to resume elective surgeries. Nearly all reporting focuses on total population rather than the critical sub-set that makes up
...more
(25)
•••
tamari
X
View Profile
View Bullboard History
Post by
tamari
on Feb 05, 2021 12:07pm
Improving U.S. vaccination & hospitalization data pave the
way to resume elective surgeries. Nearly all reporting focuses on total population rather than the critical sub-set that makes up the majority of Covid hospitalizations. Another factor is
...more
(25)
•••
tamari
X
View Profile
View Bullboard History
Post by
tamari
on Jan 16, 2021 6:55pm
Clearance of Senhance Surgical System for General Surgery
in the United States will open up Senhance to the highest volume and value procedures. Consider FDA clearance is typically expected within 6 months for filing, and TransEnterix announced
...more
(25)
•••
tamari
X
View Profile
View Bullboard History
Post by
tamari
on Jan 16, 2021 2:32pm
Resumption of elective surgeries in the COVID era:
Oregon Health & Science University. (2021, January 12). New process evaluates patients for elective surgeries following COVID-19: Published protocol believed to be the first in the COVID era
...more
(25)
•••
tamari
X
View Profile
View Bullboard History
Post by
tamari
on Dec 23, 2020 1:56pm
TransEnterix and Butterfly Among Medtech M&A Opportunities
December 23, 2020 report: https://www.gurufocus.com/news/1317568/transenterix-and-butterfly-among-medtech-ma-opportunities TransEnterix and Butterfly Among Medtech M&A Opportunities Deals
...more
Prev
1
2
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Silvercorp to Acquire Adventus for Implied Consideration of C$0.50 per Share
Meet one of the Strongest Contenders to Lead Canada’s Cannabis Market
Multiple High-Grade Gold Hits at the Tonopah Gold Project Including 90 Meters at 2.0 gpt Gold
An Opportunity to Join Pulsar Helium on the Ground in Minnesota for a Historic Reservoir Flow Test
NOI Filed for Drill Program at Lithium/Uranium Project in Nevada